CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas

Table 1

CD24 expression in human glioma tissues with different clinical-pathological features.

Clinicopathological features	No. of cases	CD24 (n)		P
		Negative	Positive
WHO grade
I	31	16	15	<0.01
II	37	12	25
III	40	8	32
IV	43	5	38
Age
<55	81	20	61	NS
≥55	70	21	49
Gender
Male	78	25	53	NS
Female	73	16	57
KPS
≥80	66	31	35	<0.01
<80	85	10	75